BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 20237897)

  • 1. Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.
    Pilko G; Besic N; Zgajnar J; Hocevar M
    Surg Oncol; 2011 Mar; 20(1):26-34. PubMed ID: 19900803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.
    Quaglino P; Ribero S; Osella-Abate S; Macrì L; Grassi M; Caliendo V; Asioli S; Sapino A; Macripò G; Savoia P; Bernengo MG
    Surg Oncol; 2011 Dec; 20(4):259-64. PubMed ID: 21145730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm.
    Egberts F; Momkvist A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A
    Tumour Biol; 2010 Jan; 31(1):8-15. PubMed ID: 20237897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
    Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
    Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma.
    G Lben K; Berberoğlu U; Altınyollar H; Kınaş V; Turanlı S
    J Cancer Res Ther; 2016; 12(2):840-4. PubMed ID: 27461661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
    Eggermont AM; Suciu S; Santinami M; Testori A; Kruit WH; Marsden J; Punt CJ; Salès F; Gore M; MacKie R; Kusic Z; Dummer R; Hauschild A; Musat E; Spatz A; Keilholz U;
    Lancet; 2008 Jul; 372(9633):117-126. PubMed ID: 18620949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Feb; 18(1):61-7. PubMed ID: 18227710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma.
    Morton DL; Cochran AJ; Thompson JF
    Ann Surg; 2007 May; 245(5):828-9. PubMed ID: 17457182
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial.
    Twomey P
    Ann Surg; 2007 Jan; 245(1):156-7. PubMed ID: 17197985
    [No Abstract]   [Full Text] [Related]  

  • 14. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?
    van Akkooi AC; de Wilt JH; Verhoef C; Schmitz PI; van Geel AN; Eggermont AM; Kliffen M
    Ann Oncol; 2006 Oct; 17(10):1578-85. PubMed ID: 16968875
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.